nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—AKR1C3—Doxorubicin—liver cancer	0.737	1	CbGbCtD
Meclofenamic acid—Niclosamide—STAT3—liver cancer	0.00846	0.615	CrCbGaD
Meclofenamic acid—Acetylsalicylic acid—TP53—liver cancer	0.00277	0.201	CrCbGaD
Meclofenamic acid—Erythema nodosum—Epirubicin—liver cancer	0.00215	0.0334	CcSEcCtD
Meclofenamic acid—Erythema nodosum—Doxorubicin—liver cancer	0.00199	0.0309	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Sorafenib—liver cancer	0.00193	0.0301	CcSEcCtD
Meclofenamic acid—Blindness—Epirubicin—liver cancer	0.00168	0.0261	CcSEcCtD
Meclofenamic acid—Blindness—Doxorubicin—liver cancer	0.00155	0.0242	CcSEcCtD
Meclofenamic acid—Neutropenia—Sorafenib—liver cancer	0.00147	0.0229	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00139	0.0217	CcSEcCtD
Meclofenamic acid—Renal failure—Sorafenib—liver cancer	0.00138	0.0215	CcSEcCtD
Meclofenamic acid—Stomatitis—Sorafenib—liver cancer	0.00137	0.0213	CcSEcCtD
Meclofenamic acid—Haemoglobin—Sorafenib—liver cancer	0.00127	0.0197	CcSEcCtD
Meclofenamic acid—Haemorrhage—Sorafenib—liver cancer	0.00126	0.0196	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Sorafenib—liver cancer	0.00119	0.0186	CcSEcCtD
Meclofenamic acid—Tinnitus—Sorafenib—liver cancer	0.00118	0.0183	CcSEcCtD
Meclofenamic acid—Alopecia—Sorafenib—liver cancer	0.00112	0.0174	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Epirubicin—liver cancer	0.00106	0.0164	CcSEcCtD
Meclofenamic acid—Nocturia—Epirubicin—liver cancer	0.001	0.0156	CcSEcCtD
Meclofenamic acid—Leukopenia—Sorafenib—liver cancer	0.000984	0.0153	CcSEcCtD
Meclofenamic acid—Ulcer—Epirubicin—liver cancer	0.000982	0.0153	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Doxorubicin—liver cancer	0.000978	0.0152	CcSEcCtD
Meclofenamic acid—Nocturia—Doxorubicin—liver cancer	0.000927	0.0144	CcSEcCtD
Meclofenamic acid—Ulcer—Doxorubicin—liver cancer	0.000909	0.0141	CcSEcCtD
Meclofenamic acid—Colitis—Epirubicin—liver cancer	0.000892	0.0139	CcSEcCtD
Meclofenamic acid—Anorexia—Sorafenib—liver cancer	0.000855	0.0133	CcSEcCtD
Meclofenamic acid—Colitis—Doxorubicin—liver cancer	0.000825	0.0128	CcSEcCtD
Meclofenamic acid—Decreased appetite—Sorafenib—liver cancer	0.00078	0.0121	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Sorafenib—liver cancer	0.000774	0.012	CcSEcCtD
Meclofenamic acid—Fatigue—Sorafenib—liver cancer	0.000773	0.012	CcSEcCtD
Meclofenamic acid—Constipation—Sorafenib—liver cancer	0.000767	0.0119	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Sorafenib—liver cancer	0.000733	0.0114	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Epirubicin—liver cancer	0.000715	0.0111	CcSEcCtD
Meclofenamic acid—Urticaria—Sorafenib—liver cancer	0.000712	0.0111	CcSEcCtD
Meclofenamic acid—Abdominal pain—Sorafenib—liver cancer	0.000709	0.011	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000661	0.0103	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP2E1—liver cancer	0.000647	0.0471	CrCbGaD
Meclofenamic acid—Asthenia—Sorafenib—liver cancer	0.000643	0.01	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP1A1—liver cancer	0.000638	0.0464	CrCbGaD
Meclofenamic acid—Pruritus—Sorafenib—liver cancer	0.000635	0.00987	CcSEcCtD
Meclofenamic acid—Diarrhoea—Sorafenib—liver cancer	0.000614	0.00955	CcSEcCtD
Meclofenamic acid—Eosinophilia—Epirubicin—liver cancer	0.000577	0.00898	CcSEcCtD
Meclofenamic acid—Vomiting—Sorafenib—liver cancer	0.00057	0.00887	CcSEcCtD
Meclofenamic acid—Neutropenia—Epirubicin—liver cancer	0.000545	0.00848	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—liver cancer	0.000534	0.00831	CcSEcCtD
Meclofenamic acid—Nausea—Sorafenib—liver cancer	0.000533	0.00829	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000515	0.00802	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—liver cancer	0.000511	0.00795	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—liver cancer	0.000507	0.00788	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—liver cancer	0.000505	0.00786	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—liver cancer	0.000504	0.00785	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Epirubicin—liver cancer	0.000485	0.00755	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—ALB—liver cancer	0.000482	0.0351	CrCbGaD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000477	0.00742	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—liver cancer	0.000473	0.00735	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—liver cancer	0.000469	0.0073	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—liver cancer	0.000469	0.00729	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—liver cancer	0.000467	0.00727	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—liver cancer	0.000467	0.00726	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Doxorubicin—liver cancer	0.000449	0.00698	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Epirubicin—liver cancer	0.000441	0.00686	CcSEcCtD
Meclofenamic acid—Tinnitus—Epirubicin—liver cancer	0.000435	0.00677	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—liver cancer	0.000434	0.00675	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—liver cancer	0.000432	0.00672	CcSEcCtD
Meclofenamic acid—Alopecia—Epirubicin—liver cancer	0.000412	0.00641	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—liver cancer	0.000408	0.00635	CcSEcCtD
Meclofenamic acid—Tinnitus—Doxorubicin—liver cancer	0.000402	0.00626	CcSEcCtD
Meclofenamic acid—Salicylic acid—ALB—liver cancer	0.000397	0.0289	CrCbGaD
Meclofenamic acid—Vision blurred—Epirubicin—liver cancer	0.000383	0.00595	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—liver cancer	0.000381	0.00593	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—liver cancer	0.000377	0.00586	CcSEcCtD
Meclofenamic acid—Malaise—Epirubicin—liver cancer	0.000366	0.0057	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—liver cancer	0.000364	0.00566	CcSEcCtD
Meclofenamic acid—Palpitations—Epirubicin—liver cancer	0.000359	0.00558	CcSEcCtD
Meclofenamic acid—Diclofenac—ALB—liver cancer	0.000355	0.0259	CrCbGaD
Meclofenamic acid—Vision blurred—Doxorubicin—liver cancer	0.000354	0.00551	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—liver cancer	0.000349	0.00542	CcSEcCtD
Meclofenamic acid—Discomfort—Epirubicin—liver cancer	0.000342	0.00531	CcSEcCtD
Meclofenamic acid—Malaise—Doxorubicin—liver cancer	0.000339	0.00527	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—liver cancer	0.000336	0.00523	CcSEcCtD
Meclofenamic acid—Palpitations—Doxorubicin—liver cancer	0.000332	0.00517	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—liver cancer	0.000331	0.00516	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—liver cancer	0.000316	0.00492	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—liver cancer	0.000316	0.00492	CcSEcCtD
Meclofenamic acid—Oedema—Doxorubicin—liver cancer	0.000307	0.00477	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—liver cancer	0.0003	0.00466	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—liver cancer	0.000298	0.00463	CcSEcCtD
Meclofenamic acid—Anorexia—Doxorubicin—liver cancer	0.000292	0.00455	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—liver cancer	0.000288	0.00448	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—liver cancer	0.000286	0.00445	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—liver cancer	0.000286	0.00445	CcSEcCtD
Meclofenamic acid—Constipation—Epirubicin—liver cancer	0.000283	0.00441	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—liver cancer	0.000277	0.00432	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—liver cancer	0.000275	0.00428	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Epirubicin—liver cancer	0.000273	0.00425	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—liver cancer	0.000271	0.00422	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—liver cancer	0.000267	0.00415	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000265	0.00412	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—liver cancer	0.000264	0.00411	CcSEcCtD
Meclofenamic acid—Urticaria—Epirubicin—liver cancer	0.000263	0.0041	CcSEcCtD
Meclofenamic acid—Constipation—Doxorubicin—liver cancer	0.000262	0.00408	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—liver cancer	0.000262	0.00408	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Doxorubicin—liver cancer	0.000253	0.00393	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—liver cancer	0.000251	0.0039	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—liver cancer	0.000244	0.00379	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—liver cancer	0.000242	0.00377	CcSEcCtD
Meclofenamic acid—Asthenia—Epirubicin—liver cancer	0.000238	0.0037	CcSEcCtD
Meclofenamic acid—Pruritus—Epirubicin—liver cancer	0.000234	0.00365	CcSEcCtD
Meclofenamic acid—Diarrhoea—Epirubicin—liver cancer	0.000227	0.00353	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—liver cancer	0.00022	0.00342	CcSEcCtD
Meclofenamic acid—Pruritus—Doxorubicin—liver cancer	0.000217	0.00338	CcSEcCtD
Meclofenamic acid—Vomiting—Epirubicin—liver cancer	0.000211	0.00328	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—liver cancer	0.00021	0.00326	CcSEcCtD
Meclofenamic acid—Nausea—Epirubicin—liver cancer	0.000197	0.00306	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—liver cancer	0.000195	0.00303	CcSEcCtD
Meclofenamic acid—Nausea—Doxorubicin—liver cancer	0.000182	0.00283	CcSEcCtD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—liver cancer	0.0001	0.00054	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—liver cancer	0.0001	0.00054	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	9.9e-05	0.000534	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MMP9—liver cancer	9.88e-05	0.000533	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—EPT1—liver cancer	9.85e-05	0.000531	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	9.77e-05	0.000527	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PRKCE—liver cancer	9.76e-05	0.000527	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CYP2E1—liver cancer	9.69e-05	0.000523	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CYP2E1—liver cancer	9.65e-05	0.000521	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	9.61e-05	0.000519	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ADAM17—liver cancer	9.38e-05	0.000506	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.38e-05	0.000506	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.34e-05	0.000504	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TAT—liver cancer	9.34e-05	0.000504	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	9.18e-05	0.000495	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CYCS—liver cancer	9.06e-05	0.000489	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CYCS—liver cancer	9.03e-05	0.000487	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	9.01e-05	0.000486	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GGT1—liver cancer	8.89e-05	0.00048	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GOT1—liver cancer	8.89e-05	0.00048	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GGT1—liver cancer	8.86e-05	0.000478	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GOT1—liver cancer	8.86e-05	0.000478	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PSMD10—liver cancer	8.82e-05	0.000476	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PSMA4—liver cancer	8.82e-05	0.000476	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	8.66e-05	0.000467	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—HRAS—liver cancer	8.51e-05	0.000459	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—HRAS—liver cancer	8.51e-05	0.000459	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—H2AFX—liver cancer	8.51e-05	0.000459	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	8.41e-05	0.000454	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MYC—liver cancer	8.16e-05	0.00044	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—IL6—liver cancer	8.15e-05	0.00044	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—IL6—liver cancer	8.15e-05	0.00044	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	8.14e-05	0.000439	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GLUL—liver cancer	8e-05	0.000431	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CPT1B—liver cancer	8e-05	0.000431	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTP1—liver cancer	7.99e-05	0.000431	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTP1—liver cancer	7.96e-05	0.000429	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	7.92e-05	0.000427	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—HMOX1—liver cancer	7.88e-05	0.000425	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—HMOX1—liver cancer	7.85e-05	0.000423	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	7.76e-05	0.000419	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MTHFR—liver cancer	7.72e-05	0.000416	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NR1H4—liver cancer	7.71e-05	0.000416	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TERT—liver cancer	7.7e-05	0.000415	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TNF—liver cancer	7.6e-05	0.00041	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTA3—liver cancer	7.58e-05	0.000409	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—LTF—liver cancer	7.58e-05	0.000409	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—AKT1—liver cancer	7.52e-05	0.000405	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—AKT1—liver cancer	7.52e-05	0.000405	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTM1—liver cancer	7.34e-05	0.000396	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTM1—liver cancer	7.31e-05	0.000395	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	7.28e-05	0.000393	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	7.26e-05	0.000391	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	7.11e-05	0.000384	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CYP1A1—liver cancer	6.96e-05	0.000375	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CYP1A1—liver cancer	6.93e-05	0.000374	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTA4—liver cancer	6.93e-05	0.000374	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	6.92e-05	0.000373	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	6.91e-05	0.000373	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.87e-05	0.000371	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	6.85e-05	0.00037	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PRKCE—liver cancer	6.83e-05	0.000369	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.78e-05	0.000366	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTA2—liver cancer	6.76e-05	0.000364	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—liver cancer	6.7e-05	0.000362	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	6.7e-05	0.000361	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	6.54e-05	0.000353	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTA1—liver cancer	6.52e-05	0.000352	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—MTHFR—liver cancer	6.49e-05	0.00035	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—APC—liver cancer	6.48e-05	0.00035	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF2—liver cancer	6.48e-05	0.000349	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—MTHFR—liver cancer	6.46e-05	0.000349	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NAT2—liver cancer	6.45e-05	0.000348	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PPARA—liver cancer	6.37e-05	0.000343	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GLUL—liver cancer	6.35e-05	0.000342	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CPT1B—liver cancer	6.35e-05	0.000342	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PPARA—liver cancer	6.34e-05	0.000342	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.2e-05	0.000334	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALDOB—liver cancer	6.18e-05	0.000333	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL6—liver cancer	6.14e-05	0.000331	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NR1H4—liver cancer	6.12e-05	0.00033	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—BRAF—liver cancer	6.09e-05	0.000329	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CSF2—liver cancer	6.05e-05	0.000326	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	6.03e-05	0.000326	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTA3—liver cancer	6.02e-05	0.000325	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—H2AFX—liver cancer	5.96e-05	0.000321	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CRABP1—liver cancer	5.89e-05	0.000318	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ALDOB—liver cancer	5.86e-05	0.000316	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.72e-05	0.000308	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CD—liver cancer	5.7e-05	0.000308	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.7e-05	0.000307	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SERPINE1—liver cancer	5.64e-05	0.000304	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.55e-05	0.0003	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.54e-05	0.000299	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTA4—liver cancer	5.5e-05	0.000297	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CG—liver cancer	5.45e-05	0.000294	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CG—liver cancer	5.43e-05	0.000293	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	5.41e-05	0.000292	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TERT—liver cancer	5.39e-05	0.000291	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.38e-05	0.00029	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTA2—liver cancer	5.36e-05	0.000289	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.31e-05	0.000286	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PPARG—liver cancer	5.26e-05	0.000284	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PPARG—liver cancer	5.24e-05	0.000283	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTA1—liver cancer	5.17e-05	0.000279	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.17e-05	0.000279	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HPGDS—liver cancer	5.15e-05	0.000278	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.13e-05	0.000277	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.12e-05	0.000276	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NAT2—liver cancer	5.12e-05	0.000276	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RAF1—liver cancer	5.09e-05	0.000275	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MTOR—liver cancer	4.97e-05	0.000268	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CB—liver cancer	4.97e-05	0.000268	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KDR—liver cancer	4.93e-05	0.000266	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.92e-05	0.000265	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALDOB—liver cancer	4.91e-05	0.000265	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK14—liver cancer	4.9e-05	0.000264	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	4.89e-05	0.000264	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ESR1—liver cancer	4.8e-05	0.000259	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CD—liver cancer	4.79e-05	0.000259	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CD—liver cancer	4.77e-05	0.000258	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—F2—liver cancer	4.74e-05	0.000256	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ALB—liver cancer	4.73e-05	0.000255	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.71e-05	0.000254	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ALB—liver cancer	4.71e-05	0.000254	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CRABP1—liver cancer	4.68e-05	0.000252	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.67e-05	0.000252	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1B—liver cancer	4.66e-05	0.000252	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ADAM17—liver cancer	4.63e-05	0.00025	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.61e-05	0.000248	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PSMA4—liver cancer	4.59e-05	0.000248	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PSMD10—liver cancer	4.59e-05	0.000248	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.56e-05	0.000246	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APC—liver cancer	4.54e-05	0.000245	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CG—liver cancer	4.54e-05	0.000245	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GOT2—liver cancer	4.47e-05	0.000241	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CTNNB1—liver cancer	4.41e-05	0.000238	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PSMA4—liver cancer	4.35e-05	0.000235	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PSMD10—liver cancer	4.35e-05	0.000235	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1A—liver cancer	4.3e-05	0.000232	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BRAF—liver cancer	4.27e-05	0.00023	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GOT2—liver cancer	4.23e-05	0.000228	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.21e-05	0.000227	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP2E1—liver cancer	4.2e-05	0.000227	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CB—liver cancer	4.18e-05	0.000225	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CB—liver cancer	4.16e-05	0.000224	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HPGDS—liver cancer	4.09e-05	0.000221	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.07e-05	0.000219	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.07e-05	0.000219	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CD—liver cancer	3.99e-05	0.000215	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SERPINE1—liver cancer	3.95e-05	0.000213	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYCS—liver cancer	3.93e-05	0.000212	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GGT1—liver cancer	3.86e-05	0.000208	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GOT1—liver cancer	3.86e-05	0.000208	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.85e-05	0.000208	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—STAT3—liver cancer	3.84e-05	0.000207	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.7e-05	0.0002	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.66e-05	0.000197	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GOT1—liver cancer	3.66e-05	0.000197	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PSMA4—liver cancer	3.65e-05	0.000197	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PSMD10—liver cancer	3.65e-05	0.000197	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MYC—liver cancer	3.57e-05	0.000192	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RAF1—liver cancer	3.56e-05	0.000192	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TGFB1—liver cancer	3.56e-05	0.000192	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GOT2—liver cancer	3.55e-05	0.000191	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MTOR—liver cancer	3.48e-05	0.000188	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CB—liver cancer	3.48e-05	0.000188	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTP1—liver cancer	3.46e-05	0.000187	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HMOX1—liver cancer	3.42e-05	0.000184	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRKCE—liver cancer	3.37e-05	0.000182	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP2E1—liver cancer	3.33e-05	0.00018	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—liver cancer	3.3e-05	0.000178	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1B—liver cancer	3.27e-05	0.000176	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.23e-05	0.000174	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CASP3—liver cancer	3.2e-05	0.000173	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2—liver cancer	3.2e-05	0.000172	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTM1—liver cancer	3.18e-05	0.000172	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYCS—liver cancer	3.12e-05	0.000168	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—liver cancer	3.11e-05	0.000168	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JUN—liver cancer	3.11e-05	0.000168	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CTNNB1—liver cancer	3.08e-05	0.000166	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GOT1—liver cancer	3.06e-05	0.000165	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GGT1—liver cancer	3.06e-05	0.000165	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CA—liver cancer	3.03e-05	0.000163	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MMP9—liver cancer	3.02e-05	0.000163	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1A1—liver cancer	3.02e-05	0.000163	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1A—liver cancer	3.01e-05	0.000163	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK8—liver cancer	2.94e-05	0.000159	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—H2AFX—liver cancer	2.94e-05	0.000159	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTHFR—liver cancer	2.81e-05	0.000152	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—liver cancer	2.8e-05	0.000151	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARA—liver cancer	2.76e-05	0.000149	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTP1—liver cancer	2.75e-05	0.000148	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—liver cancer	2.72e-05	0.000146	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HMOX1—liver cancer	2.71e-05	0.000146	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—STAT3—liver cancer	2.69e-05	0.000145	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—liver cancer	2.68e-05	0.000145	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTHFR—liver cancer	2.67e-05	0.000144	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—liver cancer	2.66e-05	0.000143	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CA—liver cancer	2.55e-05	0.000137	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CA—liver cancer	2.54e-05	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTM1—liver cancer	2.53e-05	0.000136	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MYC—liver cancer	2.5e-05	0.000135	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TGFB1—liver cancer	2.49e-05	0.000134	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.48e-05	0.000134	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—liver cancer	2.47e-05	0.000133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1A1—liver cancer	2.4e-05	0.000129	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CG—liver cancer	2.36e-05	0.000128	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—liver cancer	2.31e-05	0.000125	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARG—liver cancer	2.28e-05	0.000123	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APC—liver cancer	2.24e-05	0.000121	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTHFR—liver cancer	2.23e-05	0.00012	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARA—liver cancer	2.19e-05	0.000118	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CA—liver cancer	2.12e-05	0.000114	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BRAF—liver cancer	2.11e-05	0.000114	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—liver cancer	2.08e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CD—liver cancer	2.08e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—liver cancer	2.07e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—liver cancer	2.05e-05	0.000111	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALB—liver cancer	2.05e-05	0.000111	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CD—liver cancer	1.97e-05	0.000106	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.97e-05	0.000106	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—liver cancer	1.96e-05	0.000106	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SERPINE1—liver cancer	1.95e-05	0.000105	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—liver cancer	1.88e-05	0.000101	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CG—liver cancer	1.88e-05	0.000101	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CB—liver cancer	1.81e-05	9.77e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARG—liver cancer	1.81e-05	9.77e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RAF1—liver cancer	1.76e-05	9.49e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—liver cancer	1.73e-05	9.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTOR—liver cancer	1.72e-05	9.26e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CB—liver cancer	1.72e-05	9.26e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CD—liver cancer	1.65e-05	8.9e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALB—liver cancer	1.63e-05	8.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1B—liver cancer	1.61e-05	8.69e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CTNNB1—liver cancer	1.52e-05	8.21e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1A—liver cancer	1.49e-05	8.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CB—liver cancer	1.44e-05	7.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT3—liver cancer	1.33e-05	7.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MYC—liver cancer	1.23e-05	6.65e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFB1—liver cancer	1.23e-05	6.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—liver cancer	1.14e-05	6.15e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CA—liver cancer	1.1e-05	5.96e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CA—liver cancer	1.05e-05	5.65e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—liver cancer	9.68e-06	5.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—liver cancer	9.27e-06	5e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—liver cancer	9.02e-06	4.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CA—liver cancer	8.77e-06	4.73e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—liver cancer	8.55e-06	4.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—liver cancer	7.16e-06	3.86e-05	CbGpPWpGaD
